Publications
565 results found
Bertrand ME, Fox KM, Remme WJ, et al., 2009, Angiotensin-converting enzyme inhibition with perindopril in patients with prior myocardial infarction and/or revascularization: A subgroup analysis of the EUROPA trial, ARCHIVES OF CARDIOVASCULAR DISEASES, Vol: 102, Pages: 89-96, ISSN: 1875-2136
- Author Web Link
- Cite
- Citations: 7
de Werf FV, Bax J, Betriu A, et al., 2009, Proceeding in acute myocardial infraction with persistent non-ST segment elevation., KARDIOLOGIA POLSKA, Vol: 67, Pages: S53-S98, ISSN: 0022-9032
Ferrari R, Fox K, 2009, Insight into the Mode of Action of ACE Inhibition in Coronary Artery Disease The Ultimate 'EUROPA' Story, DRUGS, Vol: 69, Pages: 265-277, ISSN: 0012-6667
- Author Web Link
- Cite
- Citations: 39
Bousser MG, Amarenco P, Chamorro A, et al., 2009, The Prevention of Cerebrovascular and Cardiovascular Events of Ischemic Origin with Terutroban in Patients with a History of Ischemic Stroke or Transient Ischemic Attack (PERFORM) Study: Baseline Characteristics of the Population, CEREBROVASCULAR DISEASES, Vol: 27, Pages: 608-613, ISSN: 1015-9770
- Author Web Link
- Cite
- Citations: 29
Bousser MG, Amarenco P, Chamorro A, et al., 2009, Rationale and Design of a Randomized, Double-Blind, Parallel-Group Study of Terutroban 30 mg/day versus Aspirin 100 mg/day in Stroke Patients: The Prevention of Cerebrovascular and Cardiovascular Events of Ischemic Origin with Terutroban in Patients with a History of Ischemic Stroke or Transient Ischemic Attack (PERFORM) Study, CEREBROVASCULAR DISEASES, Vol: 27, Pages: 509-518, ISSN: 1015-9770
- Author Web Link
- Cite
- Citations: 60
Fox K, Ford I, Steg PG, et al., 2008, Ivabradine in heart failure: what about digoxin? Reply, LANCET, Vol: 372, Pages: 2113-2114, ISSN: 0140-6736
Kristensen SD, Baumgartner H, Casadei B, et al., 2008, Highlights of the 2008 Scientific Sessions of the European Society of Cardiology Munich, Germany, August 30 to September 3, 2008., J Am Coll Cardiol, Vol: 52, Pages: 2032-2042
Van de Werf F, Bax J, Betriu A, et al., 2008, Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation, EUROPEAN HEART JOURNAL, Vol: 29, Pages: 2909-2945, ISSN: 0195-668X
- Author Web Link
- Cite
- Citations: 1918
Turnbull F, Woodward M, Neal B, et al., 2008, Do men and women respond differently to blood pressure-lowering treatment? Results of prospectively designed overviews of randomized trials, EUROPEAN HEART JOURNAL, Vol: 29, Pages: 2669-2680, ISSN: 0195-668X
- Author Web Link
- Cite
- Citations: 195
Brugts JJ, de Maat M, Boersma E, et al., 2008, Strong and Independent Association between Angiotensinogen Gene Polymorphisms and Hypertension in 10060 Patients with Stable Coronary Artery Disease, 81st Annual Scientific Session of the American-Heart-Association, Publisher: LIPPINCOTT WILLIAMS & WILKINS, Pages: S729-S729, ISSN: 0009-7322
Brugts JJ, Boersma E, Deckers JW, et al., 2008, The Treatment Effect of Perindopril is Consistent in All Patients with Vascular Disease or High Risk of Vascular Disease: A Combined Analysis of Three Perindopril Trials, 81st Annual Scientific Session of the American-Heart-Association, Publisher: LIPPINCOTT WILLIAMS & WILKINS, Pages: S1138-S1138, ISSN: 0009-7322
Fox K, Ford I, Steg PG, et al., 2008, Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial, LANCET, Vol: 372, Pages: 817-821, ISSN: 0140-6736
- Author Web Link
- Cite
- Citations: 653
Fox K, Ford I, Steg PG, et al., 2008, Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial, LANCET, Vol: 372, Pages: 807-816, ISSN: 0140-6736
- Author Web Link
- Cite
- Citations: 803
Brugts JJ, De Maat MPM, Boersma E, et al., 2008, Functional polymorphisms in the angiotensinogen gene are associated with hypertension in patients with stable coronary artery disease, EUROPEAN HEART JOURNAL, Vol: 29, Pages: 102-103, ISSN: 0195-668X
Brugts JJ, De Maat MPM, Boersma E, et al., 2008, Promotor polymorphisms of the angiotensinogen gene are associated with hypertension in patients with stable CAD, EUROPEAN HEART JOURNAL, Vol: 29, Pages: 658-658, ISSN: 0195-668X
Brugts JJ, Boersma E, Deckers JW, et al., 2008, Consistent treatment effect of perindopril in patients with vascular disease or high risk of vascular disease: A combined analysis of three perindopril trials, EUROPEAN HEART JOURNAL, Vol: 29, Pages: 602-602, ISSN: 0195-668X
- Author Web Link
- Cite
- Citations: 1
Fox K, 2008, Benefits of perindopril all along the cardiovascular continuum: the level of evidence, EUROPEAN HEART JOURNAL SUPPLEMENTS, Vol: 10, Pages: G4-G12, ISSN: 1520-765X
- Author Web Link
- Cite
- Citations: 2
Daly C, Tavazzi L, Fox K, 2008, Inadequate control of heart rate in patients with stable angina: results from the European Heart Survey, EUROPEAN HEART JOURNAL, Vol: 29, Pages: 204-205, ISSN: 0195-668X
- Author Web Link
- Cite
- Citations: 2
de Silva R, Fox K, 2008, Early intervention in acute coronary syndrome: is bivalirudin monotherapy an effective antithrombotic strategy?, NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE, Vol: 5, Pages: 308-309, ISSN: 1743-4297
Daly CA, Stepinska J, Deptuch T, et al., 2008, Differences in presentation and management of stable angina from east to west in Europe: A comparison between Poland and the UK, INTERNATIONAL JOURNAL OF CARDIOLOGY, Vol: 125, Pages: 311-318, ISSN: 0167-5273
- Author Web Link
- Cite
- Citations: 6
Fox K, Borer JS, Camm AJ, et al., 2008, Resting heart rate and cardiovascular disease: The beta-blocker-hypertension paradox - Reply, JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, Vol: 51, Pages: 331-332, ISSN: 0735-1097
- Author Web Link
- Cite
- Citations: 1
Ferrari R, Ford I, Fox K, et al., 2008, The BEAUTIFUL study: Randomized trial of ivabradine in patients with stable coronary artery disease and left ventricular systolic dysfunction baseline characteristics of the study population, CARDIOLOGY, Vol: 109, Pages: 271-282, ISSN: 0008-6312
Objectives: Ivabradine is a selective heart rate-lowering agent that acts by inhibiting the pacemaker current I-f in sinoatrial node cells. Patients with coronary artery disease and left ventricular dysfunction are at high risk of death and cardiac events, and the BEAUTIFUL study was designed to evaluate the effects of ivabradine on outcome in such patients receiving optimal medical therapy. This report describes the study population at baseline. Methods: BEAUTIFUL is an international, multicentre, randomized, double-blind trial to compare ivabradine with placebo in reducing mortality and cardiovascular events in patients with stable coronary artery disease and left ventricular systolic dysfunction (ejection fraction <40%). Results: A total of 10,917 patients were randomized. At baseline, their mean age was 65 years, 83% were male, 98% Caucasian, 88% had previous myocardial infarction, 37% had diabetes, and 40% had metabolic syndrome. Mean ejection fraction was 32% and resting heart rate was 71.6 bpm. Concomitant medications included beta-blockers (87%), renin-angiotensin system agents (89%), antithrombotic agents (94%), and lipid-lowering agents (76%). Conclusions: Main results from BEAUTIFUL are expected in 2008, and should show whether ivabradine, on top of optimal medical treatment, reduces mortality and cardiovascular events in this population of high-risk patients. Copyright (c) 2007 S. Karger AG, Basel.
Fox K, Recena JB, Garcia-Aranda VL, et al., 2008, The BEAUTIFUL study:: Randomized trial of ivabradine in patients with stable coronary artery disease and left ventricular systolic dysfunction baseline characteristics of the study population, CARDIOLOGY, Vol: 110, Pages: 271-282, ISSN: 0008-6312
- Author Web Link
- Cite
- Citations: 38
Fox K, Steg PG, 2008, Elevated heart rate proven to increase coronary events., Cardiovasc J Afr, Vol: 19, Pages: 276-278, ISSN: 1995-1892
Kristensen SD, Baumgartner H, Drexler H, et al., 2007, Highlights of the 2007 scientific sessions of the European Society of Cardiology Vienna, Austria, September 1-5, 2007., J Am Coll Cardiol, Vol: 50, Pages: 2421-2430
Thygesen K, Alpert JS, White HD, et al., 2007, Universal definition of myocardial infarction., Circulation, Vol: 116, Pages: 2634-2653
Brugts JJ, Boersma E, Chonchol M, et al., 2007, The cardioprotective effects of the angiotensin-converting enzyme inhibitor perindopril in patients with stable coronary artery disease are not modified by mild to moderate renal insufficiency, JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, Vol: 50, Pages: 2148-2155, ISSN: 0735-1097
- Author Web Link
- Cite
- Citations: 41
Daly CA, Hildebrandt P, Bertrand M, et al., 2007, Adverse prognosis associated with the metabolic syndrome in established coronary artery disease: data from the EUROPA trial, HEART, Vol: 93, Pages: 1406-1411, ISSN: 1355-6037
- Author Web Link
- Cite
- Citations: 42
Brugts JJ, Boersma E, Chonchoi M, et al., 2007, The cardioprotective effects of the angiotensin-converting enzyme inhibitor perindopril in patients with stable coronary artery disease are not modified by mild to moderate renal insufficiency: Results from the Europa-trial, 80th Annual Scientific Session of the American-Heart-Association, Publisher: LIPPINCOTT WILLIAMS & WILKINS, Pages: 783-783, ISSN: 0009-7322
Thygesen K, Alpert JS, White HD, et al., 2007, Universal definition of myocardial infarction, EUROPEAN HEART JOURNAL, Vol: 28, Pages: 2525-2538, ISSN: 0195-668X
- Author Web Link
- Cite
- Citations: 1190
This data is extracted from the Web of Science and reproduced under a licence from Thomson Reuters. You may not copy or re-distribute this data in whole or in part without the written consent of the Science business of Thomson Reuters.